Pay in 4 interest-free payments of $6.44 Learn more
Ships within 48 hours · Estimated delivery Oct 9 - Oct 14
[DOI] [Google Scholar] 113.Leite C.B.S., Coelho J.M., Muehlmann L.A., Azevedo R.B
Circulating Tumor DNA (ctDNA) for Surveillance Liquid biopsy technologies to detect ctDNA from NF1-deficient or TP53-mutant clones are being developed for monitoring disease recurrence or transformation in high-risk NF1 patients
Kim Y, Park IH, Shin J, Choi J, Jeon C, Jeon S, et al
The significant factors affecting half-life include the sequence of a peptide, modifications, administration routes, and the amount of the peptide (dose)
This combination provides synergistic benefits targeting multiple healing pathways
US$ 29.16
US$ 28.14
US$ 27.01
US$ 29.25
US$ 29.65
US$ 29.72
US$ 26.85
US$ 29.23
US$ 25.30
